The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

EDIT FINANCIAL STATEMENTS

Editas Medicine Inc — balance sheet, income statement and cash flow trends

EDITEditas Medicine Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0100 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue47 M $Gross Profit26.7 M $ · 57%Operating Income-82.1 M $ · -175%Pre-tax Income-73.9 M $ · -157%Net Income to Owners-73.9 M $ · -157%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue47 M $+20.8%
Gross Profit26.7 M $—
Operating Income-82.1 M $—
EBITDA-70.2 M $—
Net Income to Owners-73.9 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets237.4 M
  • Equity105.3 M $44%
  • Current Liabilities68.4 M $29%
  • Long-term Liabilities63.6 M $27%

Key Figures

YoY change
Total Assets237.4 M $+12.7%
Total Liabilities132.1 M $-31.0%
Total Equity105.3 M $+448.7%
Cash & ST Investments211.6 M $+18.6%
Total Debt15.5 M $-26.6%
Net Debt-166.3 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M050 M-119.9 M $Operating9.9 M $Investing152 M $Financing42.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-119.9 M $—
Capital Expenditures691 K $-80.7%
Free Cash Flow-120.6 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on EDIT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.